| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 287,3 k € | +5.2% | 273,1 k € | +54.4% | 176,9 k € | -4.8% | 185,7 k € | +4.0% | 178,6 k € | +56.7% | 113,9 k € | -8.8% | 125,0 k € | +2.1% | 122,4 k € | +2.9% | 118,9 k € | +34.3% | 88,5 k € | +16.4% | 76,0 k € | +2.2% | 74,4 k € | -26.8% | 101,6 k € | +35.0% | 75,2 k € | -15.9% | 89,4 k € | -0.1% | 89,5 k € | -6.8% | 96,0 k € | -5.1% | 101,2 k € | +32.9% | 76,1 k € | +11.3% | 68,4 k € | |
| EBITDA | 283,0 k € | +5.2% | 268,9 k € | +55.5% | 172,9 k € | -5.4% | 182,8 k € | +4.2% | 175,4 k € | +58.6% | 110,6 k € | -8.8% | 121,2 k € | +1.9% | 119,0 k € | +3.4% | 115,0 k € | +33.9% | 85,9 k € | +17.5% | 73,1 k € | +3.6% | 70,6 k € | -28.3% | 98,5 k € | +33.3% | 73,9 k € | -14.4% | 86,3 k € | -1.6% | 87,7 k € | -6.9% | 94,1 k € | -6.0% | 100,1 k € | +33.2% | 75,2 k € | +12.6% | 66,8 k € | |
| Operating profit | 256,1 k € | +6.3% | 240,9 k € | +69.6% | 142,0 k € | -11.2% | 159,8 k € | +2.3% | 156,3 k € | +77.2% | 88,2 k € | -10.8% | 98,8 k € | +1.7% | 97,2 k € | +4.6% | 92,9 k € | +45.2% | 64,0 k € | +35.6% | 47,2 k € | +6.1% | 44,5 k € | -27.6% | 61,5 k € | +34.5% | 45,7 k € | -13.8% | 53,0 k € | -10.5% | 59,3 k € | +0.5% | 59,0 k € | -18.4% | 72,2 k € | +43.9% | 50,2 k € | +21.2% | 41,4 k € | |
| Profit/loss | 186,7 k € | +13.2% | 165,0 k € | +63.7% | 100,8 k € | +0.7% | 100,1 k € | -5.3% | 105,7 k € | +81.7% | 58,2 k € | -10.9% | 65,3 k € | -2.1% | 66,7 k € | +19.2% | 56,0 k € | +84.7% | 30,3 k € | +13.9% | 26,6 k € | -13.4% | 30,7 k € | -24.5% | 40,7 k € | +36.1% | 29,9 k € | +172.8% | 11,0 k € | -73.5% | 41,3 k € | -2.1% | 42,2 k € | -15.0% | 49,6 k € | +49.8% | 33,1 k € | -6.0% | 35,2 k € | |
| Equity | 1,1 M € | +20.6% | 904,7 k € | +22.3% | 739,7 k € | +15.8% | 639,0 k € | +18.6% | 538,9 k € | +24.4% | 433,2 k € | +15.5% | 375,0 k € | +21.1% | 309,8 k € | -42.2% | 535,6 k € | +11.7% | 479,6 k € | +6.7% | 449,3 k € | +6.3% | 422,7 k € | -0.4% | 424,5 k € | +10.6% | 383,8 k € | +8.4% | 353,9 k € | +3.2% | 342,9 k € | +15.3% | 297,5 k € | +16.5% | 255,3 k € | +24.1% | 205,7 k € | +19.2% | 172,6 k € | |
| Total assets | 1,2 M € | +19.8% | 968,4 k € | +20.7% | 802,0 k € | +11.6% | 718,9 k € | -7.8% | 780,1 k € | +20.1% | 649,3 k € | +9.4% | 593,4 k € | +9.9% | 540,1 k € | -28.7% | 757,7 k € | +6.9% | 708,6 k € | +6.1% | 668,1 k € | +5.2% | 635,3 k € | +8.1% | 588,0 k € | +6.9% | 549,8 k € | +4.2% | 527,6 k € | +4.6% | 504,6 k € | +5.9% | 476,7 k € | +6.6% | 447,3 k € | +8.9% | 410,9 k € | +14.2% | 359,9 k € | |
| Cash | 259,8 k € | +21.3% | 214,2 k € | -59.4% | 527,2 k € | +17.2% | 449,9 k € | -23.4% | 587,7 k € | +31.6% | 446,6 k € | +22.8% | 363,7 k € | +21.3% | 299,9 k € | -1.9% | 305,7 k € | +28.8% | 237,3 k € | +16.8% | 203,1 k € | -38.3% | 329,2 k € | +26.7% | 259,9 k € | +39.4% | 186,4 k € | +35.3% | 137,7 k € | -20.3% | 172,9 k € | +238.0% | 51,1 k € | -51.4% | 105,3 k € | -20.4% | 132,2 k € | -23.4% | 172,6 k € | |
| Debts | 64,6 k € | +7.0% | 60,4 k € | -1.3% | 61,2 k € | -19.1% | 75,6 k € | -67.6% | 233,1 k € | +12.3% | 207,6 k € | -1.4% | 210,7 k € | -5.6% | 223,2 k € | +3.7% | 215,3 k € | -3.2% | 222,3 k € | +4.7% | 212,4 k € | +2.2% | 207,8 k € | +30.8% | 158,8 k € | -1.7% | 161,5 k € | -4.7% | 169,5 k € | +7.7% | 157,3 k € | -10.4% | 175,5 k € | -7.1% | 188,8 k € | -6.7% | 202,4 k € | +9.7% | 184,5 k € | |
Private limited company · Kortemark · incorporated on 28/05/1996
Private limited company profitable and well capitalised. Cash position rising (+21.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dokter Johan Crevits is a Private limited company incorporated in 1996. Its main activity is: General medical practice activities. Its registered office is in Kortemark.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette